Lubor Gaal is Director of Timber Pharmaceuticals, Inc.. Currently has a direct ownership of 6,100 shares of TMBR, which is worth approximately $0. The most recent transaction as insider was on Apr 15, 2023, when has been sold 4,100 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.1K
0% 3M change
0% 12M change
Total Value Held $0

Lubor Gaal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 15 2023
BUY
Grant, award, or other acquisition
-
4,100 Added 40.2%
6,100 Common Stock, par valu...
Apr 15 2022
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock, par valu...
LG

Lubor Gaal

Director
Basking Ridge, NJ

Track Institutional and Insider Activities on TMBR

Follow Timber Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMBR shares.

Notify only if

Insider Trading

Get notified when an Timber Pharmaceuticals, Inc. insider buys or sells TMBR shares.

Notify only if

News

Receive news related to Timber Pharmaceuticals, Inc.

Track Activities on TMBR